Eisai
4523.T
#2011
Rank
C$11.20 B
Marketcap
$39.74
Share price
-0.53%
Change (1 day)
-38.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): C$0.58 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.06 Billion. In 2023 the company made an earning of C$0.75 Billion, an increase over its 2022 earnings that were of -C$32.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.58 B-22.26%
2023 C$0.75 B-2392.87%
2022 -C$32.85 Million-103.6%
2021 C$0.91 B-39.52%
2020 C$1.50 B7.3%
2019 C$1.40 B17.23%
2018 C$1.19 B86.06%
2017 C$0.64 B-23.64%
2016 C$0.84 B27.28%
2015 C$0.66 B22.08%
2014 C$0.54 B-46.11%
2013 C$1.00 B-21.67%
2012 C$1.28 B-20.72%
2011 C$1.62 B-8.44%
2010 C$1.77 B18.85%
2009 C$1.49 B